NIH supports large-scale implementation research to improve adoption and reach of evidence-based HIV prevention, treatment, and care in U.S. communities significantly impacted by HIV.
Funder: National Institutes of Health
Due Dates: June 21, 2027 (Applications) | October 20, 2027 (Applications) | June 20, 2028 (Applications) | October 20, 2028 (Applications) | June 20, 2029 (Applications)
Funding Amounts: $7 million estimated program funding, 10 expected awards; R61 up to $750,000 direct costs/year; maximum five years total
Summary: Supports large-scale implementation research advancing evidence-based HIV prevention, treatment, and care in U.S. communities significantly impacted by HIV.
Key Information: Preliminary data, implementation science frameworks, meaningful community engagement, and measurable R61-to-R33 transition milestones are required.
This NIH opportunity supports strategies to improve the uptake, implementation, sustainment, scale, and spread of evidence-based HIV prevention, treatment, and care interventions. Projects should address U.S. populations facing significantly higher HIV burden and offer substantial research and public health impact. Large single-site, multisite, and comparative studies are encouraged where scientifically appropriate.
The phased R61/R33 award supports start-up and planning followed by a possible implementation phase. Research interests include expanding novel HIV tools, technology-enabled care, integrated services across the lifespan, and interventions addressing co-occurring conditions and measurable contextual or behavioral factors. Hybrid implementation-effectiveness studies, full implementation trials, pragmatic designs, and novel implementation science methods may fit. Partnerships between academic and implementing organizations are central to the program.